Is evidence for homoeopathy reproducible?
We tested, under independent conditions, the reproducibility of evidence from two previous trials that homoeopathy differs from placebo. The test model was again homoeopathic immunotherapy. 28 patients with allergic asthma, most of them sensitive to house-dust mite, were randomly allocated to receive either oral homoeopathic immunotherapy to their principal allergen or identical placebo. The test treatments were given as a complement to their unaltered conventional care. A daily visual analogue scale of overall symptom intensity was the outcome measure. A difference in visual analogue score in favour of homoeopathic immunotherapy appeared within one week of starting treatment and persisted for up to 8 weeks (p = 0.003). There were similar trends in respiratory function and bronchial reactivity tests. A meta-analysis of all three trials strengthened the evidence that homoeopathy does more than placebo (p = 0.0004). Is the reproducibility of evidence in favour of homoeopathy proof of its activity or proof of the clinical trial's capacity to produce false-positive results?
Reilly
D
D
University Department of Medicine, Glasgow Royal Infirmary, UK.
Taylor
M A
MA
Beattie
N G
NG
Campbell
J H
JH
McSharry
C
C
Aitchison
T C
TC
Carter
R
R
Stevenson
R D
RD
D000328:Adult; D000485:Allergens / Q000276:immunology / Q000627:therapeutic use*; D000704:Analysis of Variance; D000818:Animals; D001249:Asthma / Q000503:physiopathology / Q000628:therapy*; D002985:Clinical Protocols; D004311:Double-Blind Method; D005189:False Positive Reactions; D005260:Female; D006705:Homeopathy; D006801:Humans; D007167:Immunotherapy; D008297:Male; D008925:Mites / Q000276:immunology; D015656:Respiratory Mechanics; D006255:Rhinitis, Allergic, Seasonal / Q000628:therapy*; D016896:Treatment Outcome
D000485:Allergens